Rafał Rzepka

Prof. Rafał Rzepka


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2026 in Cancers
Verified
Journal Article
Open access
PDF file
JPJustyna Pisarska
Justyna Pisarska
AKAleksandra Kożańska
Aleksandra Kożańska
RRRafał Rzepka
Rafał Rzepka
KBKatarzyna Baldy-Chudzik
Katarzyna Baldy-Chudzik
Background: Human papillomavirus (HPV)-based screening has substantially improved sensitivity for cervical cancer detection but remains limited by low specificity, leading to unnecessary colposcopy referrals. MicroRNAs (miRNAs) represent promising biomarkers for improving triage of HPV-positive women. This study evaluated the diagnostic and regulatory roles of selected miRNAs in cervical lesion progression using liquid-based cytology (LBC) specimens. Methods: Expression of six biologically relevant miRNAs (miR-15a-5p, miR-16-5p, miR-20b-5p, miR-155-5p, miR-34a-5p, and miR-140-3p) was analyzed across NILM, CIN II, CIN III, and cervical cancer (CC) samples. All miRNA analyses were performed using residual cellular material derived from the same liquid-based cytology (LBC) specimens collected during the HPV screening visit, without requiring any additional sampling prior to colposcopy. Diagnostic performance was assessed using ROC analysis. To capture regulatory dynamics beyond expression magnitude, correlation, and differential correlation (Δρ), network analyses were applied. Results: Stage-dependent changes in miRNA expression were observed across disease categories; however, expression magnitude alone did not fully explain diagnostic performance. Upregulated miRNAs, particularly miR-16-5p, miR-20b-5p, and miR-155-5p, demonstrated high diagnostic accuracy for distinguishing NILM from high-grade lesions and invasive cancer. In contrast, downregulated miRNAs showed limited diagnostic utility. Correlation analyses revealed progressive remodeling of miRNA co-expression networks, with the most pronounced changes occurring during the CIN II–to–CIN III transition. Notably, miRNAs with strong diagnostic performance did not uniformly function as network hubs, indicating distinct roles as biomarkers versus regulators of network dynamics. Conclusions: Cervical lesion progression is characterized not only by changes in miRNA expression levels but also by stage-specific reorganization of miRNA regulatory networks. Integrating diagnostic performance with network-level analysis enables improved identification of clinically robust triage markers and provides additional insight into regulatory instability associated with progression.

17 March 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
BPBanach Paulina
Banach Paulina
JKJustyna Kuczkowska
Justyna Kuczkowska
YAYulia Areshchanka
Yulia Areshchanka
WBWeronika Banach
Weronika Banach
JRJakub Rafał Rzepka
Jakub Rafał Rzepka
RRRafał Rzepka
Rafał Rzepka
Background/Objectives: This article presents the case of a 31-year-old primigravida who experienced acute liver failure in the 23rd week of pregnancy, along with a review of the literature on this rare condition during pregnancy. The purpose of this publication is to highlight the diagnostic and therapeutic challenges associated with acute liver failure in pregnant women. Methods: The patient presented with jaundice, pruritus, and dark-colored urine. Laboratory tests revealed a significant increase in aminotransferase, bilirubin, and bile acid levels, suggesting liver problems; however, due to the patient’s rapidly deteriorating condition and test results, autoimmune hepatitis was considered. Viral infections and other causes of liver damage were excluded. No clear diagnosis was established. The patient was administered ursodeoxycholic acid and due to her worsening condition, a cesarean section was performed at 23 weeks of gestation. After delivery, the patient’s condition improved, although she did experience cardiac arrest during hospitalization. The patient was discharged with a diagnosis of acute liver failure in the course of an overlap syndrome of autoimmune hepatitis and primary cholangitis or intrahepatic cholestasis of pregnancy. No abnormalities were noted during a follow-up visit 6 weeks after delivery. Despite a detailed case analysis, a final diagnosis was not established, which complicates planning for future pregnancies. Discussion: Several liver conditions can occur during pregnancy, including intrahepatic cholestasis of pregnancy, primary biliary cholangitis, and autoimmune hepatitis. Diagnosing these conditions can be challenging due to overlapping symptoms and metabolic and immunological adaptations during pregnancy that can affect the course of liver diseases. Rapid intervention is crucial to protect the health of both the mother and the fetus. Conclusions: In summary, this article aims to increase awareness of the complexities surrounding acute liver failure during pregnancy, highlighting the diagnostic challenges and importance of prompt medical intervention for the well-being of both the mother and the child. This paper aims to provide a comprehensive overview of the complexities surrounding acute liver failure during pregnancy, aiming to improve the understanding, diagnosis, and management of this condition.